Akihiro Ohira Selected Research

trans-sodium crocetinate (crocetin)

1/2012

Traditional Japanese herbal (kampo) medicines and treatment of ocular diseases: a review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiro Ohira Research Topics

Disease

7	Glaucoma 01/2017 - 02/2004
7	Cataract (Cataracts) 08/2014 - 02/2002
6	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2017 - 02/2002
5	Macular Degeneration (Age-Related Maculopathy) 05/2018 - 01/2008
3	Exfoliation Syndrome 12/2020 - 01/2012
3	Retinal Degeneration 03/2019 - 09/2011
2	Gliosis 01/2019 - 01/2016
2	Uveitis 01/2012 - 07/2009
1	Anterior Uveitis 12/2020
1	Corneal Ulcer 12/2020
1	Body Weight (Weight, Body) 05/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Stroke (Strokes) 05/2013
1	Retinal Artery Occlusion 04/2013
1	Myopia 09/2012
1	Epiretinal Membrane (Epiretinal Membranes) 05/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Asthenopia (Eyestrain) 01/2012
1	Macular Edema 10/2011
1	Gyrate Atrophy 09/2011
1	Retinal Detachment (Retinal Detachments) 01/2009
1	Amyloidosis 01/2009
1	Photosensitivity Disorders (Photodermatitis) 05/2008
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2008
1	Polypoidal Choroidal Vasculopathy 01/2008
1	Choroidal Neovascularization 01/2008
1	Cicatrix (Scar) 01/2008
1	Neoplasms (Cancer) 07/2004
1	Corneal Injuries 07/2003
1	Pituitary Neoplasms (Pituitary Adenoma) 04/2003
1	Cerebral Infarction 03/2002
1	Hyphema 02/2002
1	Myopia 10 02/2002

Drug/Important Bio-Agent (IBA)

12	Retinaldehyde (Retinal)IBA 01/2019 - 03/2002
4	AntioxidantsIBA 05/2018 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 03/2019 - 05/2008
2	Antiglaucoma AgentsIBA 01/2017 - 02/2002
2	LuteinIBA 09/2012 - 01/2008
2	ZeaxanthinsIBA 09/2012 - 01/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2020
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 03/2019
1	QuercetinIBA 03/2019
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 03/2019
1	LipidsIBA 10/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Ranibizumab (Lucentis)FDA Link 01/2017
1	Sulfur HexafluorideIBA 01/2016
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2015
1	Alprostadil (Muse)FDA LinkGeneric 04/2013
1	Interleukin-8 (Interleukin 8)IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	CytokinesIBA 01/2012
1	tetramethylpyrazineIBA 01/2012
1	baicalinIBA 01/2012
1	keishibukuryoganIBA 01/2012
1	oren gedoku toIBA 01/2012
1	sairei-toIBA 01/2012
1	wogoninIBA 01/2012
1	kakkon-toIBA 01/2012
1	xygan-ming-mu-tangIBA 01/2012
1	trans-sodium crocetinate (crocetin)IBA 01/2012
1	BerberineIBA 01/2012
1	baicaleinIBA 01/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2011
1	CyclodextrinsIBA 10/2011
1	Ophthalmic Solutions (Eye Drops)IBA 10/2011
1	Macular PigmentIBA 09/2011
1	OrnithineIBA 09/2011
1	Retinal Pigments (Pigments, Visual)IBA 05/2008
1	Free RadicalsIBA 05/2008
1	4-hydroxyhexenalIBA 05/2008
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 05/2008
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2008
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2008
1	Carotenoids (Carotene)IBA 01/2008
1	ConnexinsIBA 11/2005
1	von Willebrand FactorIBA 07/2004
1	Carteolol (Carteolol Hydrochloride)FDA LinkGeneric 07/2003
1	Hydroxyl RadicalIBA 07/2003
1	rebamipideIBA 07/2003

Therapy/Procedure

3	Intraocular Lens Implantation 08/2014 - 02/2002
3	Intraocular Lenses (Intraocular Lens) 09/2011 - 10/2002
3	Trabeculectomy (Trabeculoplasty) 01/2009 - 02/2002
2	Vitrectomy 01/2016 - 05/2012
2	Phacoemulsification 10/2002 - 02/2002
1	Oral Administration 05/2018
1	Catheters 01/2016
1	Filtering Surgery 01/2015
1	Solid-State Lasers 01/2015
1	Intravenous Injections 01/2012
1	Decompression 01/2009
1	Lasers (Laser) 04/2003